- Fraudulent Email Warning（27KB）
News Release
- July 18, 2024
- Notice Regarding Acquisition of Plant Site for Manufacturing Medical Devices in the USA (63KB)
- April 10, 2024
- Nipro Pharma Odate Plant Receives U.S. Food and Drug Administration (FDA) Certification as a Manufacturing Site (42KB)
- April 5, 2024
- Instruction for New Employees from President Sano at Induction Ceremony on April 1, 2024 (162KB)
IR News
- June 26, 2024
- Notice of Resolutions at the 71st Annual General Meeting of Shareholders
- June 3, 2024
- Notice of the 71st Annual General Meeting of Shareholders
- May 28, 2024
- IR Materials
Our Business
Meeting the needs of front line medical treatment with unique products and technologies
To meet the needs of the front line of medical treatment, NIPRO creates unique products at its four research and development sites while leveraging the technologies cultivated in its various businesses.
Mission, Vision, Value
We will work as a truly global comprehensive medical manufacturer with a willingness to consider patient and user viewpoints.
